Eyeworld

FEB 2016

EyeWorld is the official news magazine of the American Society of Cataract & Refractive Surgery.

Issue link: https://digital.eyeworld.org/i/634026

Contents of this Issue

Navigation

Page 113 of 132

People Vic Noble Head of Marketing, Ophthalmics Ms. Noble has a proven track record developing and launching brands over the last 20 years. She is a passionate leader with expertise in leveraging strategy, creative, and technology to help brands build enduring relation- ships with their customers, while driving sales. Most recently, Ms. Noble served as the Consumer Marketing Lead for the Ophthalmics Business Unit. Chris Pearson Commercial Strategy Lead, Ophthalmics Mr. Pearson began his career at Shire more than 17 years ago, and has since developed an expertise in brand management, launch preparation, and commercial strategy. He has worked across multiple business units at the company, providing commercial direction for the early development of Shire's specialty pharmaceutical portfolio. Robert Dempsey Vice President, Head of Ophthalmics Mr. Dempsey comes to Shire with more than 23 years of senior leader- ship experience focused in the area of eyecare. Prior to joining Shire, he served in multiple leadership positions in ophthalmics, overseeing the cre- ation and execution of overall medical strategy for commercial and pipeline products. Susan Benton Head of Business Development, Ophthalmics With more than 25 years of commer- cial business experience in ophthal- mology, Ms. Benton has extensive expertise in business development, strategic and brand marketing, and trade sales and distribution. Steven Zhang, MD, PhD Dr. Zhang brings deep medical affairs experience in systemic and topical anti-infectives and anti- inflammatories, including several years in ophthalmology. He also has a strong background in medical affairs lifecycle management and post-market clinical development. Scott Hunter ECP Marketing Lead, Ophthalmics Mr. Hunter brings more than 12 years of eyecare industry experience focused on therapies spanning ocular inflam- mation and pain, bacterial conjunctivitis, glaucoma, and uveitis. His strong background in the ophthal- mic pharmaceutical industry, which ranges from clinical research to market analytics and marketing, provides the expertise that will help the company build a strong position in the eyecare space. Reza Haque, MD, PhD Clinical Therapeutic Head, Ophthalmics Dr. Haque brings more than 20 years of experience in ophthalmics research and development, clinical devel- opment, project management, and medical affairs to the team. He has been involved in a number of ophthal- mics New Drug Applications and has been an essential contributor to several pharmaceutical eyecare products. 100 YEARS OF EYECARE EXPERIENCE 44 EYECARE PRODUCT LAUNCHES Shire's Ophthalmics team by the numbers EYECARE BRANDS 37 + 3

Articles in this issue

Archives of this issue

view archives of Eyeworld - FEB 2016